Pediatric HIV Infection: Drug Development for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 20, 2019
April 11, 2024
2fd110e1-e45d-44ba-8efb-87a9ba7b8d23
Related Documents
Atopic Dermatitis: Timing of Pediatric Studies During Development of Systemic Drugs
Guidance DocumentOctober 3, 2018Center for Drug Evaluation and Research
Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry: Guidance for Industry
Guidance DocumentSeptember 24, 2019Center for Drug Evaluation and Research
Bacterial Vaginosis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 1, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.